Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 13/20 | 0.57 |
| ▸ | MET | P08581 | 10/20 | 0.57 |
| ▸ | INSR | P06213 | 2/20 | 0.51 |
| ▸ | PTK2 | Q05397 | 5/20 | 0.50 |
| ▸ | CDC7 | O00311 | 1/20 | 0.50 |
| ▸ | PLK4 | O00444 | 1/20 | 0.50 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.50 |
| ▸ | AURKA | O14965 | 1/20 | 0.50 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.50 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.50 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.50 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.50 |
| ▸ | JAK2 | O60674 | 1/20 | 0.50 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.50 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.50 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.50 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.50 |
| ▸ | PAK4 | O96013 | 1/20 | 0.50 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL885228 | 0.96 | ALK (0.61) | ALKMETINSRPTK2CDC7 | |
| SCHEMBL884995 | 0.91 | ALK (0.62) | ALKMETINSRPTK2CDC7 | |
| SCHEMBL884984 | 0.88 | ALK (0.61) | ALKMETINSRPTK2CDC7 | |
| SCHEMBL2908518 | 0.87 | ALK (0.64) | ALKMETINSRPTK2CDC7 | |
| SCHEMBL884803 | 0.87 | ALK (0.64) | ALKMETINSRPTK2CDC7 | |
| SCHEMBL884578 | 0.86 | AXL (0.51) | ALKMETINSRPTK2AURKA | |
| SCHEMBL884649 | 0.84 | ALK (0.64) | ALKMETINSRPTK2CDC7 | |
| SCHEMBL2913381 | 0.84 | ALK (0.63) | ALKMETINSRPTK2CDC7 | |
| SCHEMBL884607 | 0.84 | ALK (0.63) | ALKMETINSRPTK2CDC7 | |
| SCHEMBL884883 | 0.83 | MET (0.60) | ALKMETINSRPTK2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3708564-B1 | A SOLID FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE | VERTEX PHARMA (US) | 2024-10-09 | — | — | EP | disclosed |
| EP-3708564-A1 | A SOLID FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE | Vertex Pharmaceuticals Incorporated (US) | 2020-09-16 | — | — | EP | disclosed |
| EP-3219705-B1 | PHARMACEUTICAL COMPOSITIONS OF THE AMORPHOUS FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE | VERTEX PHARMA (US) | 2020-03-11 | — | — | EP | disclosed |
| EP-3219705-A1 | PHARMACEUTICAL COMPOSITIONS OF THE AMORPHOUS FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE | Vertex Pharmaceuticals Incorporated (US) | 2017-09-20 | — | — | EP | disclosed |
| EP-3037415-A1 | SOLID FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE | Vertex Pharmaceuticals Inc. (US) | 2016-06-29 | — | — | EP | disclosed |
| EP-2838882-A1 | SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE | Vertex Pharmaceuticals Incorporated (US) | 2015-02-25 | — | — | EP | disclosed |
| EP-2547658-A1 | SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE | Vertex Pharmaceuticals Incorporated (US) | 2013-01-23 | — | — | EP | disclosed |
| EP-2222647-A1 | FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS | Cephalon, Inc. (US) | 2010-09-01 | — | — | EP | disclosed |
| EP-2222304-A2 | SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-09-01 | — | — | EP | disclosed |
| WO-2008051547-A1 | FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS | CEPHALON, INC. (US) | 2008-05-02 | — | — | WO | disclosed |